Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lucas B. Zeiger
Observed names:
L. B. Zeiger,
Lucas B Zeiger,
Lucas Zeiger,
Zeiger, Lucas,
Zeiger, Lucas B
Institution:
Cancer Research UK Scotland Institute
Observed institutions:
Innsbruck Medical University,
Universität Innsbruck,
Cancer Research UK Scotland Institute,
University of Glasgow
ORCID:
0000-0002-8712-3112
Observed ORCID:
0000-0002-8712-3112
OpenAlex ID:
A5023014716
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
2021
·
Arafath K. Najumudeen
, Fatih Ceteci
, et al.
·
Nature Genetics
·
307
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells
2018
·
D. J. Huels
, L. Bruens
, et al.
·
Nature Communications
·
108
PDF
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target
2023
·
Johan Vande Voorde
, Rory T. Steven
, et al.
·
Nature Metabolism
·
70
PDF
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance
2025
·
Mark White
, Megan L. Mills
, et al.
·
Nature
·
53
The haemochromatosis gene Hfe and Kupffer cells control LDL cholesterol homeostasis and impact on atherosclerosis development
2020
·
Egon Demetz
, Piotr Tymoszuk
, et al.
·
European Heart Journal
·
52
Implications of Peak Selection in the Interpretation of Unsupervised Mass Spectrometry Imaging Data Analyses
2021
·
Teresa Murta
, Rory T. Steven
, et al.
·
Analytical Chemistry
·
34
A RAC-GEF network critical for early intestinal tumourigenesis
2021
·
K. A. Pickering
, K. Gilroy
, et al.
·
Nature Communications
·
27
PDF
Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta
2025
·
Richard J.A. Goodwin
, John F. Marshall
, et al.
·
Cancer Discovery
·
4
MassIVE MSV000103511 - SLC7A5 drives PI3K-mutant intestinal cancer model progression and its deletion enhances MAPK-targeted therapy response
2026
·
Owen Sansom
, Andrew Campbell
, et al.
·
UC San Diego
List of Consortium Members from Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta
2025
·
Richard J.A. Goodwin
, John F. Marshall
, et al.
Data from Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta
2025
·
Richard J.A. Goodwin
, John F. Marshall
, et al.
List of Consortium Members from Visualizing Cancer Heterogeneity at the Molecular and Cellular Levels: Lessons from Rosetta
2025
·
Richard J.A. Goodwin
, John F. Marshall
, et al.
The amino acid transporter SLC7A5 drives progression of PI3K-mutant intestinal cancer models and enhances response to MAPK-targeted therapy
2024
·
Owen Sansom
, Lucas Zeiger
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
16
Citation count:
656
H-index:
7
I10-index:
7
Year
Topic
Type